Avenue Income Credit Strategies (ACP) 12.79 $ACP Avenue

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2016 at 7:02 AM

Avenue Income Credit Strategies (ACP) 12.79 $ACP

Avenue Income Credit Strategies Fund September Monthly Dividend
PR Newswire - Thu Sep 01, 3:05PM CDT
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, September 1, 2016, a monthly dividend of $0.12 per share of Common Stock, payable September 30, 2016 to shareholders of record at the close of business on September 12, 2016. Ex-date will be September 8, 2016.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund Portfolio Data
PR Newswire - Wed Aug 03, 3:05PM CDT
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, today announced that portfolio data as of June 30, 2016, including performance, top ten largest holdings, top five industry holdings, and certain portfolio weightings, is now available to the public on the Fund's website at www.avenuecapital.com under "Strategies - Avenue Income Credit Strategies Closed-End Fund."
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund August Monthly Dividend
PR Newswire - Mon Aug 01, 3:05PM CDT
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, August 1, 2016, a monthly dividend of $0.12 per share of Common Stock, payable August 31, 2016 to shareholders of record at the close of business on August 11, 2016. Ex-date will be August 9, 2016.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund June Monthly Dividend
PR Newswire - Wed Jun 01, 3:05PM CDT
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, June 1, 2016, a monthly dividend of $0.12 per share of Common Stock, payable June 30, 2016 to shareholders of record at the close of business on June 13, 2016. Ex-date will be June 9, 2016.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund May Monthly Dividend
PR Newswire - Mon May 02, 3:05PM CDT
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, May 2, 2016, a monthly dividend of $0.12 per share of Common Stock, payable May 31, 2016 to shareholders of record at the close of business on May 12, 2016. Ex-date will be May 10, 2016.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund announces dividend of USD0.12 per share for February 2016
M2 - Tue Feb 02, 3:03AM CST
Avenue Income Credit Strategies Fund (NYSE:ACP) released on Monday a monthly dividend of USD0.12 per share on its common stock.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund February Monthly Dividend
PR Newswire - Mon Feb 01, 3:01PM CST
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, February 1, 2016, a monthly dividend of $0.12 per share of Common Stock, payable February 29, 2016 to shareholders of record at the close of business on February 11, 2016. Ex-date will be February 9, 2016.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund declare dividend of USD0.12 per share for January 2016
M2 - Tue Dec 22, 3:01AM CST
Avenue Income Credit Strategies Fund (NYSE:ACP) on Monday declared a monthly common stock dividend of USD0.12 per share for January 2016.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund January Monthly Dividend
PR Newswire - Mon Dec 21, 3:01PM CST
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, December 21, 2015, a monthly dividend of $0.12 per share of Common Stock, payable January 14, 2016 to shareholders of record at the close of business on December 31, 2015. Ex-date will be December 29, 2015.
ACP: 12.79 (+0.07)

Avenue fund declares December dividend
M2 - Tue Dec 08, 5:32AM CST
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, has declared a monthly dividend of USD0.12 per share of common stock. The dividend is payable December 16, 2015 to shareholders of record at the close of business on December 11, 2015. The Fund's investment adviser is Avenue Capital Management II, L.P., part of Avenue Capital Group. Avenue Capital Group has invested in the public and private debt and equity securities of distressed companies across a variety of industries since 1995.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund December Monthly Dividend
PR Newswire - Tue Dec 01, 3:01PM CST
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, December 1, 2015, a monthly dividend of $0.12 per share of Common Stock, payable December 16, 2015 to shareholders of record at the close of business on December 11, 2015. Ex-date will be December 9, 2015.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund November Monthly Dividend
PR Newswire - Mon Nov 02, 3:01PM CST
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, November 2, 2015, a monthly dividend of $0.12 per share of Common Stock, payable November 30, 2015 to shareholders of record at the close of business on November 12, 2015. Ex-date will be November 10, 2015.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund October Monthly Dividend
PR Newswire - Thu Oct 01, 3:01PM CDT
Avenue Income Credit Strategies Fund (NYSE: ACP), a closed-end management investment company, declared on this date, October 1, 2015, a monthly dividend of $0.12 per share of Common Stock, payable October 30, 2015 to shareholders of record at the close of business on October 12, 2015. Ex-date will be October 8, 2015.
ACP: 12.79 (+0.07)

Avenue Income Credit Strategies Fund declares USD0.12 per share dividend for August
M2 - Tue Aug 04, 4:33AM CDT
Avenue Income Credit Strategies Fund (NYSE:ACP) announced on Monday that it will pay a common stock dividend of USD0.12 per share for August.
ACP: 12.79 (+0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...